Evolent Health (EVH) Shares Outstanding (2013 - 2026)

Evolent Health has reported Shares Outstanding for 14 years, with the latest figure at $118.4 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 0.9% year-over-year to $118.4 million; the trailing twelve-month figure through Mar 2026 stood at $118.4 million (up 0.9% YoY), and the FY2025 full-year result was $117.6 million, up 0.88% from the prior year.
• Shares Outstanding for Q1 2026 stood at $118.4 million, up from $117.6 million in the prior quarter.
• The five-year high for Shares Outstanding was $118.4 million in Q1 2026, with the low at $91.6 million in Q1 2022.
• Average Shares Outstanding over 5 years is $111.5 million, with a median of $116.2 million recorded in 2024.
• Year-over-year, Shares Outstanding rose 23.38% in 2023 and grew 0.87% in 2025.
• Tracing EVH's Shares Outstanding over 5 years: stood at $101.5 million in 2022, then grew by 13.72% to $115.4 million in 2023, then climbed by 1.0% to $116.6 million in 2024, then increased by 0.88% to $117.6 million in 2025, then gained by 0.72% to $118.4 million in 2026.
• The last three Shares Outstanding figures came in at $118.4 million (Q1 2026), $117.6 million (Q4 2025), and $117.6 million (Q3 2025), per Business Quant data.

Peer Comparison